caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1992715387

Maya MoorleyM.D.

Internal MedicineHuntington, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Maya Moorley's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 12 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MOUNT SINAI HOSPITAL2141,094
NPI 128564017752133
REITER, JOEL3268
Northwell Health Laboratories
Clinical Laboratory · New Hyde Park, NY
23173
Kenneth Walsh
Internal Medicine · Huntington, NY
16117
Tamara Mohuchy
Diagnostic Radiology · Bedford Hills, NY
1535
Paul Edgecomb
Internal Medicine · Mangonia Park, FL
1536
KAMHI, EDOUARD1454
Brianne Blumenthal
Diagnostic Radiology · Huntington, NY
1330
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Melville, NY
1262
Peter Berman
Otolaryngology · Melville, NY
1127
Linh Dinh
Internal Medicine · New York, NY
1140
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,627
Unique beneficiaries
—
Total services
1,997
Distinct HCPCS
12
Medicare payment
$130K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 7,864 Internal Medicine providers in NY — top quintile (cohort median 552).
PRESCRIBING · PART D · 2024
Total Rx claims
4,046
Beneficiaries
—
Total drug cost
$250K
Distinct drugs
81
Brand share
16.6%
Top prescribed drugs
Atorvastatin Calcium341 claims
Rosuvastatin Calcium273 claims
Amlodipine Besylate220 claims
Levothyroxine Sodium209 claims
Losartan Potassium181 claims
QUALITY · MIPS · 2024
Final MIPS score
93.1
Quality
79.8
Cost
0.0
Improvement activities
40.0
Promoting interop.
88.8
Payment adjustment
0.76%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.